Will omicron wipe out delta forever? By Stephanie Pappas published 7 January 22 Omicron is sweeping away the delta variant, having impacts on hospitalization and population immunity.
Rapid tests may not detect omicron early in infection By Nicoletta Lanese published 6 January 22 However, PCR tests, which are more sensitive, detected the virus in the early days of infection.
Omicron may cause milder disease. A lab study hints at why. By Nicoletta Lanese published 25 December 21 The omicron variant of SARS-CoV-2 may be less efficient at infiltrating the lungs and spreading from cell to cell, early lab studies suggest.
Breakthrough COVID cases may supercharge immunity, study hints By Nicoletta Lanese published 17 December 21 There may be a silver lining to breakthrough infections, although they obviously still carry risks.
The coronavirus infects fat cells, study suggests By Nicoletta Lanese published 9 December 21 Yet-to-be-reviewed research suggests the coronavirus infects fat cells and certain immune cells in fat.
Newfound flavor of omicron variant may be harder to track By Nicoletta Lanese published 8 December 21 The newfound version, BA.2, may be slightly harder to track.
Omicron variant may have evolved in rats, one theory says By Nicoletta Lanese published 2 December 21 Some features of the omicron variant's genome hint that it may have evolved in rodents.
1st case of omicron variant in US confirmed in California By Yasemin Saplakoglu published 1 December 21 U.S. officials confirmed the first U.S. case of omicron in California.
The Omicron variant: What we know so far By Yasemin Saplakoglu published 29 November 21 On Nov. 26, the World Health Organization (WHO) named a new coronavirus variant "Omicron" and designated it as a "variant of concern."
FDA authorizes Pfizer and Moderna COVID-19 booster shots for all adults By Yasemin Saplakoglu published 19 November 21 On Friday (Nov. 19), The Food and Drug Administration (FDA) authorized Moderna and Pfizer boosters for all adults, prior to the busy holiday season.
California and Colorado start COVID-19 booster shots for all adults By Yasemin Saplakoglu published 12 November 21 California and Colorado expanded booster shot eligibility to all adults who received their second dose of Moderna's or Pfizer's COVID-19 vaccine at least six months ago.
Antiviral pill cuts COVID-19 hospitalizations and deaths by 89%, Pfizer says By Yasemin Saplakoglu published 5 November 21 A new COVID-19 pill significantly cuts risk of hospitalization or death when taken within three days of symptom onset, Pfizer says.
FDA panel recommends Pfizer vaccine for children ages 5 to 11 By Yasemin Saplakoglu published 26 October 21 The FDA panel concluded that the benefits of Pfizer's COVID-19 vaccine for young children outweigh the risks.
'Rogue' antibodies found in brains of teens with delusions and paranoia after COVID-19 By Nicoletta Lanese published 25 October 21 Autoantibodies may sometimes be involved in the psychiatric effects of COVID-19.
Moderna says COVID-19 vaccine is safe and effective in children By Yasemin Saplakoglu published 25 October 21 The company plans to submit their data to regulatory agencies soon.
Woman infected with COVID-19 for 335 days — longest on record By Yasemin Saplakoglu published 21 October 21 A woman who survived cancer was infected with the novel coronavirus for nearly a year, in the longest-ever reported case of COVID-19, according to a new study.
Should you mix and match COVID-19 vaccines? By Yasemin Saplakoglu published 21 October 21 Many people will now be able to "mix and match" COVID-19 booster shots — that is, get a different COVID-19 vaccine for a booster, the FDA announced Wednesday (Oct. 20).
Colin Powell's weakened immune system may have played a role in his COVID-19 death By Nicoletta Lanese published 18 October 21 Powell had previously undergone treatment for a blood cancer that can harm the immune system.
FDA advisory committee recommends Moderna COVID-19 vaccine booster By Yasemin Saplakoglu published 14 October 21 An advisory committee voted unanimously on Thursday (Oct. 14) to recommend a Moderna COVID-19 vaccine booster for certain groups of people.
We might finally know what causes 'COVID toes' By Nicoletta Lanese published 7 October 21 The rashes may emerge due to a runaway immune response.
